Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Twist Bioscience Corporation TWST

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throu...


Recent & Breaking News (NDAQ:TWST)

Twist Bioscience to Report Fiscal 2021 Third Quarter Financial Results on Friday, August 6, 2021

Business Wire July 21, 2021

Twist Bioscience Acquires NGS Library Preparation Maker iGenomX

Business Wire June 30, 2021

Dovetail Genomics Announces New Capture Hi-C Targeted Enrichment Panels

PR Newswire June 16, 2021

Twist Bioscience Collaborates with Regeneron for Production of Genotyping by Sequencing Panel to Enable Diverse Genome-wide Screening

Business Wire June 14, 2021

Twist Bioscience Announces Fireside Chat and Presentation at BIO Digital

Business Wire June 14, 2021

DNA Data Storage Alliance Publishes First White Paper, Launches Website

Business Wire June 10, 2021

Twist Bioscience Begins Shipping of Synthetic RNA Controls for Kappa (B.1.617.1) SARS-CoV-2 Variants for Development of Accurate Tests

Business Wire June 8, 2021

Twist Bioscience Launches Enzymatic Fragmentation Library Preparation Kit for High Uniformity, High-Yield Amplification, Streamlined Next Generation Sequencing Workflow for Targeted Applications

Business Wire May 25, 2021

Twist Bioscience to Present at Upcoming Virtual Conferences

Business Wire May 25, 2021

Twist Bioscience Supports the Engineering Biology Research Consortium as it Publishes Statement of Ethics

Business Wire May 13, 2021

Twist Bioscience Reports Second Quarter Fiscal 2021 Financial Results

Business Wire May 6, 2021

Twist Bioscience and Vivlion Partner to Generate gRNA Libraries for CRISPR Applications

Business Wire April 28, 2021

Twist Bioscience to Report Fiscal 2021 Second Quarter Financial Results on Thursday, May 6, 2021

Business Wire April 22, 2021

Twist Bioscience to Expand Oregon Lease, Supporting Future Growth

Business Wire April 16, 2021

Pure Biologics Selects Twist Bioscience to Expand Phage Display Technology Capabilities

Business Wire April 14, 2021

Twist Bioscience Exercises Option to Purchase Custom Designed Antibody Library and Optimization Software

Business Wire April 12, 2021

AcornMed Selects Twist Bioscience Technology to Power Next Generation Precision Medicine Tests

Business Wire April 7, 2021

Twist Bioscience to Provide Antibody Discovery, Optimization and Access to Library of Libraries for Drug Research to Stanford University Laboratories

Business Wire April 7, 2021

Twist Bioscience Earns 2021 Great Place to Work Certification(TM)

Business Wire April 5, 2021

Twist Bioscience and Kyowa Kirin Partner for GPCR Antibody Discovery

Business Wire March 25, 2021